23 Jul Tissue-specific genome engineering using CRISPR-CAS9
Abstract
The present application provides compounds, compositions, uses thereof for the treatment of diseases, conditions and/or disorders, and uses thereof as asialoglycoprotein receptor (ASGPR) targeting agents.
Year: 2017
Country: TW
Doc No: 201737944